Viral Specific T-cells (VSTs)
Sponsors
Children's Hospital Medical Center, Cincinnati
Conditions
Allogeneic Stem Cell TransplantSolid Organ TransplantViral Infection
Phase 2
Donor-Derived Viral Specific T-cells (VSTs) for Prophylaxis Against Viral Infections After Allogeneic Stem Cell Transplant
CompletedNCT03883906
Start: 2019-03-16End: 2021-10-01Updated: 2022-12-13
Viral Specific T-cells for Treatment of Viral Infections After Solid Organ Transplant
Active, not recruitingNCT04331275
Start: 2020-08-18End: 2028-09-30Updated: 2025-11-05
Viral Specific T-cells for Treatment of COVID-19
WithdrawnNCT04406064
Start: 2021-01-31End: 2025-06-30Updated: 2021-01-19